MX2022005561A - Method for improving health outcomes. - Google Patents
Method for improving health outcomes.Info
- Publication number
- MX2022005561A MX2022005561A MX2022005561A MX2022005561A MX2022005561A MX 2022005561 A MX2022005561 A MX 2022005561A MX 2022005561 A MX2022005561 A MX 2022005561A MX 2022005561 A MX2022005561 A MX 2022005561A MX 2022005561 A MX2022005561 A MX 2022005561A
- Authority
- MX
- Mexico
- Prior art keywords
- tissues
- risk
- followed
- improve
- outcomes
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 210000001519 tissue Anatomy 0.000 abstract 3
- 230000000845 anti-microbial effect Effects 0.000 abstract 2
- 230000006378 damage Effects 0.000 abstract 2
- 210000003205 muscle Anatomy 0.000 abstract 2
- 206010029803 Nosocomial infection Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000003950 pathogenic mechanism Effects 0.000 abstract 1
- 230000000737 periodic effect Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000003938 response to stress Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Method of using an antiseptic and pH modulating solution provides improved health outcomes in part by decolonizing surfaces, animate and inanimate, and improving tissue function and stress response, particularly the barrier properties and antimicrobial properties of tissues, especially skin and muscles, whether damaged or intact and at risk of damage. The method includes initial application followed by continued topical application on a periodic basis until the damaged area is restored or the risk of injury has passed, followed by continued maintenance application for a period of time thereafter. The method of using the solution is believed to restore and improve the functioning of tissues that naturally interrupt pathogenic mechanisms of disease in addition to providing antimicrobial support. The method can be adapted to improve a plurality of health or consumer care outcomes, from preventing or substantially reducing rates of hospital acquired infections to improving muscle performance and recovery, among others.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/745,091 US20160158393A1 (en) | 2014-02-21 | 2015-06-19 | Method for Improving Health Outcomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022005561A true MX2022005561A (en) | 2022-07-21 |
Family
ID=56464282
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017016911A MX2017016911A (en) | 2015-06-19 | 2016-06-17 | Method for improving health outcomes. |
| MX2022005561A MX2022005561A (en) | 2015-06-19 | 2017-12-19 | Method for improving health outcomes. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017016911A MX2017016911A (en) | 2015-06-19 | 2016-06-17 | Method for improving health outcomes. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3310443A1 (en) |
| JP (1) | JP2018521992A (en) |
| BR (1) | BR112017027349B1 (en) |
| CA (1) | CA2989644A1 (en) |
| MX (2) | MX2017016911A (en) |
| WO (2) | WO2016205620A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3107612B1 (en) | 2014-02-21 | 2025-05-21 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
| CN107693457A (en) * | 2017-11-16 | 2018-02-16 | 东兴市良佳优农林科技有限公司 | Itch-stopping shampoo |
| CN107737070A (en) * | 2017-11-16 | 2018-02-27 | 东兴市良佳优农林科技有限公司 | Sterilization, skin care hand cleaning liquid |
| JP2021155362A (en) * | 2020-03-27 | 2021-10-07 | 株式会社ナリス化粧品 | Method for inhibiting peroxynitrite activity and screening method for peroxynitrite activity inhibitor |
| JP2021159046A (en) * | 2020-04-03 | 2021-10-11 | 花王株式会社 | How to provide skin information |
| IT202000021634A1 (en) * | 2020-09-16 | 2020-12-16 | Prete Antonio Del | DEVICE FOR THE ADMINISTRATION OF A SOLUTION WITH POVIDONE IODIUM FOR THE PREVENTION OF EYE INFECTIONS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1161914A1 (en) * | 1994-02-28 | 2001-12-12 | Incline Technologies, Inc. | Method for washing the skin |
| US6358516B1 (en) * | 1998-08-21 | 2002-03-19 | Norris R. Harod | One-step system for cleansing, conditioning, and treating the skin |
| US9814737B2 (en) * | 2010-04-27 | 2017-11-14 | Mercy Medical Research Institute | Composition for skin sanitization and protection and method of its use |
| US9327029B2 (en) * | 2011-05-05 | 2016-05-03 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
-
2016
- 2016-06-17 EP EP16741722.9A patent/EP3310443A1/en active Pending
- 2016-06-17 MX MX2017016911A patent/MX2017016911A/en unknown
- 2016-06-17 CA CA2989644A patent/CA2989644A1/en active Pending
- 2016-06-17 JP JP2017565934A patent/JP2018521992A/en active Pending
- 2016-06-17 BR BR112017027349-7A patent/BR112017027349B1/en active IP Right Grant
- 2016-06-17 WO PCT/US2016/038043 patent/WO2016205620A1/en not_active Ceased
- 2016-06-20 WO PCT/US2016/038409 patent/WO2016205812A1/en not_active Ceased
-
2017
- 2017-12-19 MX MX2022005561A patent/MX2022005561A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018521992A (en) | 2018-08-09 |
| WO2016205812A1 (en) | 2016-12-22 |
| BR112017027349A2 (en) | 2018-08-21 |
| CA2989644A1 (en) | 2016-12-22 |
| EP3310443A1 (en) | 2018-04-25 |
| BR112017027349B1 (en) | 2021-07-06 |
| MX2017016911A (en) | 2019-06-24 |
| WO2016205620A1 (en) | 2016-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022005561A (en) | Method for improving health outcomes. | |
| MY160894A (en) | Oligosaccharide composition for treating skin diseases | |
| MX2020012595A (en) | Topical pharmaceutical compositions. | |
| MY204330A (en) | Water-in-oil emulsion | |
| CA2877344C (en) | Device, system, and method for transcatheter treatment of valve regurgitation | |
| BR112013025493A2 (en) | topically administrable aqueous composition for a human or animal eye, method for treating a condition involving deficiencies in natural tears in the human or animal eye, composition for topical application in the treatment of an ocular disorder or condition of the human or animal eye, method for treating an eye or human eye disorder or condition, a composition for use in treating or associated with eye or human eye pain and a method for relieving or approaching eye or human eye pain | |
| MX2016000364A (en) | METHODS TO TREAT OR PREVENT OPHTHALMOLOGICAL AFFECTIONS. | |
| BR112017002637A2 (en) | methods to treat or prevent eye conditions | |
| PH12018500044A1 (en) | Stuffy nose deblocking composition having antiviral activity | |
| BR112013018919A2 (en) | empty nanoparticle compositions and their use to treat dermatological problems | |
| AR088585A1 (en) | A MEDICINAL PRODUCT TO TREAT THE PREVIOUS EYE DISEASE | |
| MX392677B (en) | COMPOSITIONS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS IN A PARTICULAR POPULATION OF PATIENTS. | |
| HK1215674A1 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
| EA033446B1 (en) | Heterocyclic compound for treating macular degeneration and/or stargardt's disease | |
| AR097599A1 (en) | A COMPOSITION THAT INCLUDES GUAÇATONGA AND AROEIRA EXTRACT, ITS USE AND A METHOD FOR THE PREVENTION AND / OR TREATMENT OF SIGNS CAUSED BY SKIN AGING | |
| MX365366B (en) | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne. | |
| PH12019502874A1 (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
| WO2018140755A8 (en) | Tissue container systems | |
| WO2016040169A3 (en) | Mucolytic agents for use in tretaing pulmonary sarcoidosis | |
| MX367321B (en) | Skin care composition and method thereof. | |
| WO2014030992A3 (en) | Antiseptic, seboregulating and exfolitating composition for treating or preventing acne | |
| EA200702248A1 (en) | WAY OF ELIMINATING WRINKLES | |
| MX2016013741A (en) | Rapid relief of motor fluctuations in parkinson's disease. | |
| MX2017006657A (en) | Method for the prevention and treatment of acne. | |
| MX2016012761A (en) | Biocide formulation for protecting the skin, comprising pentahydrate copper salts and heptahydrate zinc salts. |